(Q54764251)

3 June 2018

title

Inclusion body myositis: clonal expansions of muscle-infiltrating T cells persist over time. (English)

1 reference

3 June 2018

main subject

inclusion body myositis

1 reference

Müntzing K

1

1 reference

3 June 2018

Lindberg C

series ordinal

2

1 reference

3 June 2018

Moslemi AR

series ordinal

3

1 reference

3 June 2018

Oldfors A

series ordinal

4

1 reference

3 June 2018

publication date

1 August 2003

1 reference

3 June 2018

Scandinavian Journal of Immunology

published in

1 reference

3 June 2018

volume

58

1 reference

3 June 2018

issue

2

1 reference

3 June 2018

page(s)

195-200

1 reference

3 June 2018

Inclusion body myositis: genetic factors, aberrant protein expression, and autoimmunity

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

21 January 2018

Inclusion body myositis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

The expression of co-stimulatory and accessory molecules on cultured human muscle cells is not dependent on stimulus by pro-inflammatory cytokines: relevance for the pathogenesis of inflammatory myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Inclusion body myositis: morphological clues to correct diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Differential expression of chemokines in inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

The αβ T-Cell Receptor Repertoire in Inclusion Body Myositis: Diverse Patterns of Gene Expression by Muscle-infiltrating Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

T cell receptor beta-chain repertoire in inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

T-cell heterogeneity in muscle lesions of inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Expression of Bcl-2 in inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Inclusion body myositis: abnormal protein accumulation does not trigger apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2003.01251.X

10.1046/J.1365-3083.2003.01251.X

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

12869141

1 reference

3 June 2018